Skip to main content
. Author manuscript; available in PMC: 2019 Nov 27.
Published in final edited form as: Ann Intern Med. 2009 Apr 7;150(7):474–484. doi: 10.7326/0003-4819-150-7-200904070-00007

Table 2.

Association Between LDL Subfractions and Incident CVD and Severity of CVD

Author, Year
(Reference)
Cardiovascular
Outcome
Participants Predictor Mean Value
P Value Other Results P Value Adjusted
for
Lipids?
Quality
Persons With Event Persons
Without
Event
Incident CVD
 Cromwell et al, 2007 (13) Incident CVD 1440 men LDL particle number 1641 nmol/L 1509 nmol/L <0.001 HR, 1.24 (95% CI, 1.10–1.39) per 1-SD increase in LDL particle number* <0.001 No Fair
1626 women 1628 1344 <0.001 HR, 1.33 (95% CI, 1.17–1.50) per 1-SD increase in LDL particle number* <0.001 No
Event-free survival was higher in participants with low LDL
particle number, after dichotomization by LDL
cholesterol level
Yes
 El Harchaoui et al, 2007 (14) Fatal or nonfatal
CAD
1003 case
patients,
1885 control participants
Large (212–230 Å)
Medium (no data on size)
Small (180–212 Å)
LDL particle number
LDL particle size
43 nmol/L
568 nmol/L
999 nmol/L
1640 nmol/L
210 Å
36 nmol/L
572 nmol/L
885 nmol/L
1525 nmol/L
211 Å
0.003 NS
<0.001
<0.001
0.002
OR, 1.37 (95% CI, 1.04–1.83)
OR, 0.86 (95% CI,
0.65–1.15)
  0.02
NS
No
No
No
Yes
No
Good
 Otvos et al, 2006 (15) Nonfatal MI or cardiac death 364 case patients, 697 control participants Large (212–230 Å) OR, 1.08 (95% CI,
0.95–1.23) per 1-SD
increase§
NS Yes Fair
Small (180–212 Å) OR, 1.11 (95% CI,
0.98–1.27) per 1-SD
increase§
NS Yes
LDL particle number OR, 1.20 (95% CI,
1.05–1.37) per 1-SD
increase§
<0.05 Yes
LDL particle size OR, 0.97 (95% CI,
0.85–1.10) per 1-SD
increase§
NS Yes
 Kuller et al,
2002 (16)
Incident MI or angina Men: 243 case patients, 67 control participants Large (213–230 Å)
Medium (198–212 Å)
Small (183–197 Å)
LDL particle number
LDL particle size
57.3 mg/dL
cholesterol
36 mg/dL
cholesterol
25.7 mg/dL
cholesterol
1676 nmol/L
209 Å
58 mg/dL
cholesterol
34.5 mg/dL
cholesterol
22.7 mg/dL
cholesterol
1597 nmol/L
210 Å
NS
NS
NS
NS
NS
No
No
No
No
No
Fair
Women: 191 case patients,
182 control participants
Large (213–230 Å)
Medium (198–212 Å)
Small (183–197 Å)
LDL particle number
LDL particle size
96 mg/dL
cholesterol
8.2 mg/dL
cholesterol
7.1 mg/dL
cholesterol
1680 nmol/L
213 Å
104 mg/dL
cholesterol
6.8 mg/dL
cholesterol
0 mg/dL
cholesterol
1501 nmol/L
216 Å
NS
NS
<0.05
<0.05
<0.05
OR, 1.77 (95% CI,
1.12–2.30), presence vs. absence of
subfraction
OR, 1.11 (95% CI,
1.03–1.09) per 100nmol/L increase OR, 0.68 (95% CI, 0.51–0.91), unit of comparison not reported
<0.05
<0.05
<0.05
No
No
Unclear
Yes
Unclear
 Kuller et al, 2007 (17) Cardiac death 214 case patients, 214 control participants Large (213–230 Å)
Small (182–197 Å)
LDL particle size
500.7 nmol/L
1207.1 nmol/L
No data
465.8 nmol/L
1200.2 nmol/L
No data
NS
NS
NS
ORs of quartiles and trend (no data)
ORs of quartiles and trend (no data)
NS
NS
No
No
No
Fair
 Hsia et al, 2008 (18)
  Substudy 1 Incident MI, coronary death 202 case patients, 200 control participants LDL particle number 1673 nmol/L 1513 nmol/L <0.001** OR, 1.40 (95% CI, 1.08–1.83) per 1-SD increase†† 0.01 No Fair
  Substudy 2 Incident MI, coronary death 149 case patients, 149 control participants LDL particle number 1687 nmol/L 1525 nmol/L <0.001 OR, 1.31 (95% CI, 0.97–1.78) per 1-SD increase 0.08 No Fair
 Blake et al, 2002 (19) Cardiac death, incident MI, or stroke 130 case patients, 130 control paraticipants Large (213–227 Å)
Medium (198–212 Å)
Small (183–197 Å)
LDL particle number
LDL particle size
886 nmol/L
201 nmol/L
0
1597 nmol/L
215 Å
1001 nmol/L
126 nmol/L
0
1404 nmol/L
218 Å
NS
0.008
NS
<0.001
0.046



RR, 2.90 (95% CI, 1.16–7.30)‡‡
RR, 1.20 (95% CI, 0.51–2.82)‡‡



  0.02
NS
No
No
No
Yes
Yes
Good
 Campbell et al, 2007 (20) Intracerebral hemorrhage 41 case patients, 107 control participants Large (no data on size)
Medium (no data on size)
Small (no data on size)
LDL particle number
LDL particle size
396 nmol/L
473 nmol/L
309 nmol/L
1461 nmol/L
208 Å
252 nmol/L
473 nmol/L
377 nmol/L
1558 nmol/L
0.03
NS
NS
NS
OR, 1.18 (95% CI, 0.98–1.43) per 100-nmol/L increase§§
OR, 2.15 (95% CI, 0.97–4.78) per 10-Å increase§§
OR, 2.16 (95% CI, 0.97–4.80) per 10-Å increase∥∥
OR, 1.53 (95% CI, 0.55–4.30) per 10-Å increase¶¶
  0.08


  0.06
NS
NS
No
No
No
No
No
Yes
Yes
Fair
 Soedamah-Muthu et al., 2003 (21)  Incident CAD 59 case patients, 59 control participants Large (213–230 Å)
Medium (198–212 Å)
Small (183–197 Å)
LDL particle size
603 nmol/L
120 nmol/L
800 nmol/L
206 Å
688 nmol/L
111 nmol/L
526 nmol/L
210 Å
NS
≤0.01
≤0.001
≤0.01
No data***
No data***
No data***
No data***
NS
NS
NS
NS
Yes
Yes
Yes
Yes
Fair
CVD severity
 Rosenson et al, 2002 (22) Change in MLD, mm

MLD decrease
>0.07 mm/y
241

111
Large (213–230 Å)
Small (183–197 Å)
Large (213–230 Å)
Small (183–197 Å)
LDL particle number
LDL particle size










Spearman correlation, 0.03
Spearman correlation, −0.17†††
OR, 0.4 (95% CI, 0.1–1.4) for <84 vs. ≥84 mg/dL
OR, 9.1 (95% CI, 2.1–39) for <30 vs. ≥30 mg/dL
OR, 1.4 (95% CI, 0.3–6.7) for <1825 vs. ≥1825 nmol/L
OR, 0.2 (95% CI, 0.1–0.9) for <200 vs. ≥200 Å
NS
<0.01 NS
<0.05
NS
<0.05
Yes
Yes
Yes
Yes
Yes
Yes
Fair

CAD coronary artery disease; CVD cardiovascular disease; HDL high-density lipoprotein; HR hazard ratio; LDL low-density lipoprotein; MI myocardial infarction; MLD minimum lumen diameter; NMR nuclear magnetic resonance; NS not statistically significant; OR odds ratio; RR risk ratio; Tg triglyceride.

*

Adjusted for age, systolic and diastolic blood pressure, smoking, and lipid medication use.

Adjusted for HDL cholesterol and Tg. Fourth quartile compared with first quartile.

Adjusted for LDL particle number. Fourth quartile compared with first quartile.

§

Adjusted for treatment group, age, hypertension, smoking, body mass index, and diabetes mellitus status.

Adjustment for LDL cholesterol, HDL cholesterol, and Tg did not “appreciably change these relations.”

Adjusted for age, race, and LDL cholesterol.

**

Adjusted for treatment group.

††

Adjusted for treatment group, age, smoking, alcohol use, diabetes, and hypertension.

‡‡

Adjusted for Tg and total cholesterol/HDL cholesterol. Fourth quartile compared with first quartile.

§§

Adjusted for matching factors.

∥∥

Adjusted for total cholesterol level.

¶¶

Adjusted for HDL cholesterol.

***

( Multivariable analysis with all predictors and Tg and HDL particle number.

†††

Adjusted for LDL cholesterol, HDL cholesterol, Tg, and other factors.

HHS Vulnerability Disclosure